Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.
about
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trialPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionColorectal cancer: Metastases to a single organStereotactic body radiation therapy for liver metastasesCancer concepts and principles: primer for the interventional oncologist-part IIConsensus report from the 7th International Forum for Liver Magnetic Resonance ImagingClinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases.A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer.Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach.Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.Update on the role of imaging in management of metastatic colorectal cancerGenetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomographyEpithelial-mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer.Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial FindingsProposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy.Resection of colorectal liver metastases: current perspectives.Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).Presurgical therapy in metastatic renal cell carcinoma.Hepatic histopathology and postoperative outcome after preoperative chemotherapy for Chinese patients with colorectal liver metastasesRisk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasisOptimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statementRebound growth of hepatic colorectal metastases after neo-adjuvant chemotherapy: effect on survival after resection.Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurementsManagement of hepatic metastases from colorectal cancerTotally laparoscopic associating liver tourniquet and portal vein occlusion for staged hepatectomy combined with simultaneous left hemicolectomy for bilateral liver metastases of the primary colon cancer: A case report.Advances in therapeutics for liver metastasis from colorectal cancer.Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effective.Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy.
P2860
Q21261279-8BA6A63D-BE6B-4B07-BAA4-8FEDDFBF9AB3Q26774687-70978E56-50EB-4A51-9F53-D8E33EE2217DQ26778009-7CB23641-E088-4060-BAFD-2B159507201AQ27008308-1C70F6B5-25F9-4E3C-8439-D7A87ED39401Q27010961-3C5E7E84-E72A-4DC0-A126-1DEFB891DEDCQ28088807-41919C2D-0609-4346-AAB5-356584646600Q33704416-A29A408F-DB75-4CD8-A6AA-E0FC8B111D8CQ33778484-7F88B9D5-7123-44A0-BD53-30DA6F8ED72FQ34036020-80CA08FE-F157-45C9-A5AC-55A8A04B187DQ34155261-02CAB67C-4BB3-49F3-9917-8B36D92A9114Q34196471-F8E2427F-0879-419E-8F4E-AA18039AAE0CQ35171584-610862FC-0C34-44AF-9BD6-895F0634400DQ35285305-2FCCA4F2-A328-4A0E-9532-6871C4337707Q35328438-DC234C28-1E73-4B42-B1B1-D45592DA39DCQ35495938-387CC6A8-D902-45CC-BB8C-F708ABC4E783Q35998461-4E6C7A2B-FC09-44DB-8B15-74D336CB94E5Q36208221-353B916E-1C8C-4C9C-8851-1787D00E4092Q36396031-11FF5229-87BB-4B22-BE58-3B41BDBBE0B4Q36402623-23F71B6D-BCF9-471E-B491-FCB02333D86DQ36409950-4FFA9C1C-E248-4ADC-B7BF-D055BAFBD899Q36444723-EBA5A47A-470D-4658-8A11-4EA53180A184Q36642970-C55404EB-3CA2-4605-A68C-A75FA44F09F8Q36691815-FB898ED5-994B-4BBF-8B68-E40DBA079286Q36736759-977ECD3F-2E95-4CE8-A2F3-C01E921DAA62Q36897483-FE9F51AD-EA6B-4062-92A6-7E373088BFD0Q36968386-5E45EF5E-2FFB-44F2-86E8-4B5EEFD5D561Q37037106-F7F2EDBF-6741-404A-8FCC-3EC8F541E0AAQ37049057-5584C0A0-A58C-4299-9FCE-CEC6E9282367Q37143641-FE197835-CAA1-4CE8-B74B-96B9AADA26C5Q37427525-FF3221A4-97B2-405B-A15B-89D4F41D228BQ37725374-6C90B8A3-FDD3-49A6-9B9F-532F9ACB1082Q37821285-6A06C488-C6A3-4C1E-B46C-D3F5444A800CQ37821841-13C29E60-3ED9-4EB3-849B-2D0702552C34Q37821845-01D36769-BB53-4AA2-925E-A8ED052A7487Q37821848-A0406BA4-59E4-4315-9C6B-7C634B7CC7C7Q37907117-F3B5EFC7-873C-4247-A29D-6EA63340AA0DQ37969833-C4949134-D302-4733-A04C-76A573AA6F83Q37972224-DFA9A640-71C6-4C6A-9B85-C6385FD26614Q38051098-101D83DD-7376-4A70-8474-3B6D377F1FB4Q38135754-C431A205-EDA5-4670-A025-37EFAE4C76FD
P2860
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@ast
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@en
type
label
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@ast
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@en
prefLabel
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@ast
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@en
P2093
P356
P1476
Neoadjuvant chemotherapy befor ...... ses from colorectal carcinoma.
@en
P2093
Baruch Brenner
Gregory D Leonard
Nancy E Kemeny
P304
P356
10.1200/JCO.2005.00.349
P407
P577
2005-03-01T00:00:00Z